Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.84
Price to sales ratio
0.58

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2202
TNDM
Tandem Diabetes Care, Inc. - Common Stock
21.40 USD+0.14%-6.10%+20.29%+42.67%1.49 B USD
2206
ATEC
Alphatec Holdings, Inc. - Common Stock
9.57 USD+1.59%+3.35%+3.01%-40.45%1.48 B USD
2303
AORT
Artivion, Inc. Common Stock
26.68 USD-1.88%-4.75%-2.95%-38.57%1.30 B USD
2358
PRCT
PROCEPT BioRobotics Corporation - Common Stock
20.60 USD-2.23%-1.90%+15.08%-42.25%1.18 B USD

Frequently asked questions about Integra LifeSciences Holdings

What is the Integra LifeSciences Holdings stock price today?

The current price of Integra LifeSciences Holdings (IART) is 16.85. Over the past 24 hours, the stock has changed by -0.18%. Follow the IART chart for real-time price dynamics.

What is the stock ticker of Integra LifeSciences Holdings?

Integra LifeSciences Holdings trades under the ticker IART. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Integra LifeSciences Holdings stock going up?

IART has changed by +0.24% over the last week, -8.92% over the last month, and +4.53% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Integra LifeSciences Holdings?

Integra LifeSciences Holdings currently has a market capitalization of 1.31 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Integra LifeSciences Holdings earnings last quarter?

Last quarter, Integra LifeSciences Holdings reported earnings of 0.06 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Integra LifeSciences Holdings revenue for the last quarter?

Integra LifeSciences Holdings reported quarterly revenue of 418.76 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Integra LifeSciences Holdings net income for the last quarter?

Integra LifeSciences Holdings reported net income of 4.48 M for the last quarter. The previous quarter showed -4.62 M, which means net income changed by +197.08%.

How many employees does Integra LifeSciences Holdings have?

As of the latest available data, Integra LifeSciences Holdings has 4 427 employees. Workforce size can provide additional context about the company's scale and operations.

What is Integra LifeSciences Holdings EBITDA?

Integra LifeSciences Holdings EBITDA is 84.42 M, and its EBITDA margin is 20.16%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Integra LifeSciences Holdings stock?

You can buy Integra LifeSciences Holdings (IART) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Integra LifeSciences Holdings stock?

Investing in Integra LifeSciences Holdings requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IART chart and related analysis on metatrader.com as part of your research.

Integra LifeSciences Holdings Corporation - Common Stock

Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery. Integra artificial skin became the first commercially reproducible skin tissue used to treat severe burns and other skin wounds.

News